Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Regulatory press release

Klaria Pharma Holding AB: Klaria Interim Report Q3 2023

Klaria Pharma Holding
Download the release

1 July - 30 September 2023

Summary of the Interim Report

Net sales of 0.6 MSEK (0.0 MSEK)

Other income amounted to 0.0 MSEK (0.0 MSEK)

Third quarter of 2023

- R&D costs for the period amounted to 7.4 MSEK (10.9 MSEK)

- Profit after tax amounted to -10.8 MSEK (16.1 MSEK) ∞ Earnings per share for the quarter amounted to -0.10 SEK (-0.27 SEK)

- Cash flow from operating activities amounted to -7.3 MSEK (-3.6 MSEK)

- Cash and cash equivalents on the balance sheet date amounted to 2.3 MSEK (6.7 MSEK)

- Cash and cash equivalents on the balance sheet date amounted to 50.7 MSEK (39.3 MSEK)

The period January-September 2023

- Net sales of 7.1 MSEK (3.7 MSEK)

- Other income amounted to 0.3 MSEK (0.4 MSEK)

- R&D costs for the period amounted to 23.0 MSEK (42.7 MSEK)

- Profit after tax amounted to -26.3 MSEK (-50.9 MSEK)

- Earnings per share for the quarter amounted to -0.27 SEK (-0.88 SEK)

- Cash flow from operating activities amounted to -18.6 MSEK (-39.1 MSEK)

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.